Skip to content

A clinical retrospective study of Lumecca IPL in the treatment of facial pigmentation and vasodilation

A clinical retrospective study of Lumecca IPL in the treatment of facial pigmentation and vasodilation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128664
Enrollment
Unknown
Registered
2026-07-23
Start date
2026-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial stain formation and skin blood vessel dilation

Interventions

Observation group:None

Sponsors

shenyang Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. A Clear Diagnosis Of Facial Pigmentation And Vasodilation Diseases; 2. Age >= 18 Years Old; 3. The Cosmetic Seeker Has Good Compliance.

Exclusion criteria

Exclusion criteria: 1. Those Combined With Other Skin Lesions Such As Congenital Nevus; 2. Those Who Received Treatments Including Chemical Peeling Or Laser Peeling Within 3 Months Prior To Treatment; 3. Pregnant Women, Patients With Severe Hepatic And Renal Diseases Or Autoimmune Diseases.

Design outcomes

Primary

MeasureTime frame
VISA photos before and after treatment;

Countries

China

Contacts

Public ContactXiaoguang Liu

shenyang Tenth People's Hospital

38104130@qq.com+86 24 88360080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026